Cat. No. 3921
Chemical Name: N-(Piperidin-1-yl)-5-(4-methoxyphen
Biological ActivityHigh affinity CB1 receptor antagonist (Ki = 4.1 nM). Exhibits significantly reduced lipophilicity compared to other CB1 antagonists.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Miller et al (2007) Analogs of SR-141716A (Rimonabant) alter d-amphetamine-evoked [3H] dopamine overflow from preloaded striatal slices and amphetamine-induced hyperactivity. Life Sci. 81 63. PMID: 17532007.
Katoch-Rouse et al (2003) Synthesis, structure-activity relationship and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity. J.Med.Chem. 46 642. PMID: 12570386.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for NIDA 41020 include:
Buznikov et al (2010) A putative 'pre-nervous' endocannabinoid system in early echinoderm development. Dev Neurosci 32 1. PMID: 19907129.
Do you know of a great paper that uses NIDA 41020 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: NIDA 41020, supplier, NIDA41020, cannabinoid, receptors, antagonists, CB1, selective, Tocris Bioscience, CB1 Receptor Antagonist products